Hmos

How BoobyBiome is unlocking the mysterious breast milk biome

05-Mar-2024 By Nikki Hancocks

Doctors Lydia Mapstone, Sioned Fôn Jones and Tara O'Driscoll founded Boobybiome in 2019 on a mission to better preserve beneficial breast milk bacteria and develop synbiotic supplements to support the infant microbiome.

Nestlé Research: Supporting infant microbiome development without compromising gut ecology

29-Feb-2024 By Olivia Haslam

The ‘ecology of strains’ is imperative to consider in the research of the infant microbiome, as not all Bifidobacterium strains work equally, Dr. Bernard Berger, R&D expert microbiome and probiotics at Nestlé Research told NutraIngredients.

Nestlé launches probiotic and HMO blend to mirror breastmilk changes

27-Oct-2023 By Nikki Hancocks

Nestlé has launched a new proprietary blend for infant nutrition combining a probiotic strain with varying levels of six human milk oligosaccharides (HMOs) to support the developing infant through its life stages.

Chr. Hansen review outlines HMO health benefits

22-Sep-2023 By Nikki Hancocks

In a new systematic review, Chr. Hansen scientists have compiled data from 26 clinical studies on HMOs, concluding there is a wealth of evidence that these are well-tolerated modulators of the gut microbiome providing health benefits.

Precision microbiome engineering study: "The level of control and precision of engraftment that we have achieved is unprecedented"

05-Sep-2023 By Danielle Masterson

Bacteria found in the gut of nursing infants combined with breast milk sugars may lead to live biotherapeutics and ultimately be a game-changer for the gut health of adults.

dsm-firmenich gets FDA GRAS for novel HMOs

16-Aug-2023 By Stephen Daniells

The US FDA has issued ‘Good Day Letters’ to dsm-firmenich for three Generally Recognized as Safe (GRAS) notices submitted for the human milk oligosaccharides (HMOs) LNFP-l/2’-FL and hypoallergenic grade LNnT and 2’-FL.

Insights from Probiota 2023

VIDEO: New discoveries and opportunities in HMO supplementation

03-Mar-2023 By Nikki Hancocks

New research into human milk oligosaccharides (HMOs) is revealing exciting new opportunities to target specific health concerns within babies and the older population.

Insights from Probiota 2023

Chr. Hansen hints at future synbiotic production following significant research findings

10-Feb-2023 By Olivia Brown

Adam Baker, director of science at Chr. Hansen, discussed recent in-house clinical trials observing an amplified response following administration of probiotics with HMOs, compared with pre- or probiotics given alone, at Probiota last week.

Research: Green environment associated with increased breastmilk HMO diversity

06-Jan-2023 By Nikki Hancocks

The 'greenness' of a mother's environment impacts the HMO composition in her breastmilk, according to a newly published study of Finnish breastfeeding women.

Researchers advise plant-rich maternal diets to improve HMOs profiles in breastmilk

11-Oct-2022 By Nicola Gordon-Seymour

Plant-derived macronutrients are positively associated with higher pregnancy and postpartum human milk oligosaccharides (HMO) in breastmilk and could help mitigate the risk of allergies among infants, according to a study funded by Abbott Nutrition.

Specific HMOs linked to infant brain development: Study

19-Sep-2022 By Stephen Daniells

Individual human milk oligosaccharides (HMOs) may play critical roles in the maturation of gray matter in an infant brain, showing that inclusion of specific HMOs in infant formula could be beneficial, says a new study.

Chr. Hansen receives landmark approvals for HMOs in global markets

16-Sep-2022 By Nicola Gordon-Seymour

Chr. Hansen has received regulatory approval to supply a range of Human Milk Oligosaccharides (HMO) to new and existing global markets, following recent endorsements from Australia and New Zealand last year.

China authority seeks public consultation on use of HMO 2’-FL in infant formula

03-May-2022 By Tingmin Koe

China’s food regulator is seeking public consultation on the use of the human milk oligosaccharide (HMO) 2’-fucosyllactose (2’-FL) in infant formula as well as in foods for toddlers and young children.

Study shows HMO levels in breast milk to aid next-gen formula development

12-Apr-2022 By Stephen Daniells

A systematic review of dozens of studies has revealed that levels of the five most prevalent HMOs in breast milk vary widely, and infant formula development should accommodate this variability.

HMO supplements may improve gut health for adults with IBS: DSM study

29-Oct-2021 By Stephen Daniells

People with irritable bowel syndrome (IBS) may benefit from supplements of human milk oligosaccharides (HMOs), with a new study showing modulation of the gut microbiota, fecal and plasma metabolite profiles.

Chr. Hansen publishes first scientific study of HMO mix in natural concentrations in infant formula

30-Aug-2021 By Jim Cornall

Human milk oligosaccharides (HMOs) are the third most abundant components exclusively found in human breast milk.

FrieslandCampina: ‘What’s exciting is combining HMOs & GOS for digestion, immunity & absorption.’

23-Aug-2021 By Will Chu

Over the last 20 years, the increase in exclusive breastfeeding and formula milk consumption, particularly in upper-middle-income countries, has led to product makers and ingredient suppliers revising plans in order to meet demand.

Ingredients that mimic breast milk to propel growth in formula space

10-Aug-2021 By Danielle Masterson

A recent analysis has found that the global infant formula ingredients market is expanding steadily with the rising middle class and the demand for high-quality infant formula gains traction.

NutraWomen Wednesday: Leila Strickland, PhD, Biomilq

28-Jul-2021 By Danielle Masterson

Biomilq is a women-owned infant nutrition company that is producing cultured breastmilk in a lab. The company’s co-founder and CSO, Leila Strickland, PhD, sat down to discuss the inspiration behind this new kind of infant formula.

Inbiose applies for FDA GRAS approval of four new fermentation-produced HMOs

06-Jul-2021 By Jim Cornall

Belgian biotech company Inbiose, which develops human milk oligosaccharides (HMOs), has submitted its application for a Generally Recognized as Safe (GRAS) approval by the US Food & Drug Administration (FDA) of four HMOs.

HMO supplementation may boost bowel function and help adults with IBS: Study

12-May-2021 By Stephen Daniells

Supplementation with the human milk oligosaccharides (HMOs) HMOs 2'-fucosyllactose (2'FL), and lacto-N-neotetraose (LNnT) may normalize bowel function and improve bloating and IBS severity in adults, says a new study.

HMO levels in human milk linked to infant cognitive development: Abbott Study

25-Feb-2021 By Stephen Daniells

Levels of two specific human milk oligosaccharides (HMOs) are linked with measure of infant cognitive development, says a pilot study led by R&D Abbott Nutrition.